Skip to main content

Advertisement

Log in

Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

All patients with urine culture-confirmed genitourinary tuberculosis (GUTB) diagnosed between 1995 and 2007 at two medical centers in northern Taiwan were included in this retrospective study. Genotypes of 48 preserved Mycobacterium tuberculosis (MTB) isolates from these patients were determined by spoligotyping and double repetitive element PCR (DRE-PCR) analysis. Among the 64 patients, 38 (59.4%) were male with a mean ±SD age of 60.3 ± 16.1 years old. The overall mortality rate was 26.2%. Poor prognostic factors included age over 65 years (HR = 4.03; 95%; CI: 1.27–12.76), cardiovascular disease (HR = 5.96; 95% CI: 1.98–17.92), receiving steroids (HR = 10.16; 95% CI: 2.27–45.47), not being treated (HR 4.81; 95% CI 1.12–20.67). Spoligotyping and DRE-PCR of the 48 MTB isolates revealed that 20 (41.7%) belonged to the Beijing family and 40 (83.3%) had a clustering pattern. Identification of a Beijing family isolate was not correlated with drug resistance or mortality. Clustering strains were likely to be resistant to isoniazid (OR = 4.71; 95% CI: 1.10 to 23.53). In this study of patients with urine culture-confirmed GUTB, age and coexisting diseases were independently associated with an unfavorable outcome. The Beijing family was the dominant genotype of GUTB isolates, but did not correlate with drug resistance or outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization: Global tuberculosis control: epidermiology, surveillance, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411.Geneva 2009. Available at: http://www.who.int/tb/publications/global_report/2009/en/index.html

  2. Mehta JB, Dutt A, Harvill L, Mathews KM (1991) Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 99:1134–1138

    Article  CAS  PubMed  Google Scholar 

  3. Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM (2002) Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis 6:879–886

    CAS  PubMed  Google Scholar 

  4. Pehme L, Hollo V, Rahu M, Altraja A (2005) Tuberculosis during fundamental societal changes in Estonia with special reference to extrapulmonary manifestations. Chest 127:1289–1295

    Article  PubMed  Google Scholar 

  5. Center for Disease Control for Taiwan: Statistics of communicable diseases and surveillance report, Republic of China, 2007. Available at: http://www.cdc.gov.tw/np.asp?ctNode=1766&mp=5

  6. Chen TM, Lee PY, Perng RP (1991) Extrapulmonary tuberculosis: experience at Veterans General Hospital-Taipei, 1985 to 1987. J Formos Med Assoc 90:1163–1170

    CAS  PubMed  Google Scholar 

  7. Gow JG (2002) Genitourinary tuberculosis. In: Walsh PC et al (eds) Campbell's urology, 8th edn. Saunders, Philadelphia

    Google Scholar 

  8. Hsieh HC, Lu PL, Chen YH, Chen TC, Tsai JJ, Chang K et al (2006) Genitourinary tuberculosis in a medical center in southern Taiwan: an eleven-year experience. J Microbiol Immunol Infect 39:408–413

    CAS  PubMed  Google Scholar 

  9. World Health Organization: Treatment of tuberculosis: guidelines for national programmes, 3rd edn. WHO/CDS/TB/2003.313.Geneva 2003. Available at: http://www.who.int/tb/publications/cds_tb_2003_313/en/index.html

  10. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN et al (2003) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167:603–662

    Article  PubMed  Google Scholar 

  11. World Health Organization: Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency Update 2008.WHO/HTM/TB/2008.402.Geneva 2008. Available at http://www.who.int/tb/publications/2008/programmatic_guidelines_for_mdrtb/en/index.html

  12. Pfyffer GE (2007) Mycobacterium: general characteristics, laboratory detection, and staining procedures. In: Patrick R, Murray EJB, James H, Jorgensen MLL, Pfaller MA (eds) Manual of clinical microbiology, vol. 1, 9th edn. American Society for Microbiology, Washington, DC

    Google Scholar 

  13. Clinical and Laboratory Standards Institute (2008) Susceptibility testing of Mycobacteria, Nocardiae, and other aeroblic Actinomycetes: approved standards. CLSI, Wayne, PA, USA

    Google Scholar 

  14. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA et al (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6:23

    Article  PubMed  Google Scholar 

  15. Friedman CR, Stoeckle MY, Johnson WD Jr, Riley LW (1995) Double-repetitive-element PCR method for subtyping Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 33:1383–1384

    CAS  PubMed  Google Scholar 

  16. Orakwe JC, Okafor PI (2005) Genitourinary tuberculosis in Nigeria; a review of thirty-one cases. Niger J Clin Pract 8:69–73

    CAS  PubMed  Google Scholar 

  17. Altintepe L, Tonbul HZ, Ozbey I, Guney I, Odabas AR, Cetinkaya R et al (2005) Urinary tuberculosis: ten years' experience. Ren Fail 27:657–661

    Article  PubMed  Google Scholar 

  18. Gokce G, Kilicarslan H, Ayan S, Tas F, Akar R, Kaya K et al (2002) Genitourinary tuberculosis: a review of 174 cases. Scand J Infect Dis 34:338–340

    Article  PubMed  Google Scholar 

  19. Centers for Disease Control, Department of Health, Executive Yuan, 2008. Republic of China: Taiwan Tuberculosis Control Report 2008. Centers for Disease Control, Department of Health, Executive Yuan, Republic of China. Available at: http://www.cdc.gov.tw/lp.asp?ctNode=1947&CtUnit=1105&BaseDSD=31&mp=1

  20. Centers for Disease Control, Department of Health, Executive Yuan, 2007. Republic of China: Taiwan Tuberculosis Control Report 2007. Centers for Disease Control, Department of Health, Executive Yuan, Republic of China. Available at: http://www.cdc.gov.tw/lp.asp?ctNode=1947&CtUnit=1105&BaseDSD=31&mp=1

  21. Nzerue C, Drayton J, Oster R, Hewan-Lowe K (2000) Genitourinary tuberculosis in patients with HIV infection: clinical features in an inner-city hospital population. Am J Med Sci 320:299–303

    Article  CAS  PubMed  Google Scholar 

  22. Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC et al (2008) Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis 47:e57–e63

    Article  CAS  PubMed  Google Scholar 

  23. Liaw YS, Hsueh PR, Yu CJ, Wang SK, Yang PC, Luh KT (2004) Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998–2002. J Formos Med Assoc 103:671–677

    CAS  PubMed  Google Scholar 

  24. Dou HY, Tseng FC, Lin CW, Chang JR, Sun JR, Tsai WS et al (2008) Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis 8:170

    Article  PubMed  Google Scholar 

  25. Feng JY, Su WJ, Tsai CC, Chang SC (2008) Clinical impact of mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. J Clin Microbiol 46:3127–3129

    Article  CAS  PubMed  Google Scholar 

  26. Jou R, Chiang CY, Huang WL (2005) Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol 43:95–100

    Article  PubMed  Google Scholar 

  27. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, Kwon OJ et al (2005) Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 63:165–172

    Article  CAS  PubMed  Google Scholar 

  28. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA (2002) Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 40:1930–1937

    Article  CAS  PubMed  Google Scholar 

  29. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K et al (2000) Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 6:302–305

    Article  CAS  PubMed  Google Scholar 

  30. Augustynowicz-Kopec E, Zwolska JT (2008) Genetic diversity of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Poland and assessed by spoligotyping. J Clin Microbiol 46:4041–4044

    Article  PubMed  Google Scholar 

  31. Werngren J, Hoffner SE (2003) Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J Clin Microbiol 41:1520–1524

    Article  CAS  PubMed  Google Scholar 

  32. Gori A, Bandera A, Marchetti G, Degli Esposti A, Catozzi L, Nardi GP et al (2005) Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis 11:1242–1248

    CAS  PubMed  Google Scholar 

  33. Bauer J, Andersen AB, Kremer K, Miörner H (1999) Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol 37:2602–2606

    CAS  PubMed  Google Scholar 

  34. Sola C, Horgen L, Maïsetti J, Devallois A, Goh KS, Rastogi N (1998) Spoligotyping followed by double-repetitive-element PCR as rapid alternative to IS6110 fingerprinting for epidemiological studies of tuberculosis. J Clin Microbiol 36:1122–1124

    CAS  PubMed  Google Scholar 

  35. Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, Hwang JJ et al (2008) The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 36:335–340

    Article  PubMed  Google Scholar 

  36. Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, Luh KT (2009) Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis 13:105–111

    PubMed  Google Scholar 

Download references

Funding

Funding for this study was provided by the Institute for Biotechnology and Medicine Industry (DOH97-DC-1501)

Conflict of interest

None of the authors has anything to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P.-R. Hsueh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsu, HL., Lai, CC., Yu, MC. et al. Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007. Eur J Clin Microbiol Infect Dis 30, 319–326 (2011). https://doi.org/10.1007/s10096-010-1083-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-010-1083-z

Keywords

Navigation